D.E. Shaw & Co
MRVI icon

D.E. Shaw & Co’s Maravai LifeSciences MRVI Stock Holding History

D.E. Shaw & Co’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-119,123
Closed -$990K – 4697
2024
Q3 		$990K Sell
119,123
-364,437
-75% -$3.15M ﹤0.01% 3278
2024
Q2 		$3.46M Sell
483,560
-1,119,676
-70% -$9.67M ﹤0.01% 2148
2024
Q1 		$13.9M Buy
1,603,236
+370,737
+30% +$2.51M 0.01% 1150
2023
Q4 		$8.07M Buy
1,232,499
+463,246
+60% +$2.99M 0.01% 1523
2023
Q3 		$7.69M Buy
769,253
+200,971
+35% +$2.21M 0.01% 1467
2023
Q2 		$7.06M Sell
568,282
-582,061
-51% -$7.86M 0.01% 1624
2023
Q1 		$16.1M Sell
1,150,343
-288,361
-20% -$4.14M 0.02% 1025
2022
Q4 		$20.6M Buy
1,438,704
+621,160
+76% +$9.78M 0.02% 896
2022
Q3 		$20.9M Buy
817,544
+330,568
+68% +$8.29M 0.02% 819
2022
Q2 		$13.8M Buy
486,976
+106,595
+28% +$3.38M 0.02% 1143
2022
Q1 		$13.4M Buy
380,381
+431
+0.1% +$14.4K 0.01% 1333
2021
Q4 		$15.9M Sell
379,950
-264,852
-41% -$10.7M 0.01% 1253
2021
Q3 		$31.6M Buy
644,802
+308,421
+92% +$15M 0.03% 758
2021
Q2 		$14M Buy
+336,381
New +$13M 0.01% 1234

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co's MRVI Position: Q4 2024 in Review

D.E. Shaw & Co sold out of Maravai LifeSciences (MRVI) in Q4 2024, closing a stake of 119,123 shares — an estimated $990K sold.

D.E. Shaw & Co first reported a position in MRVI in Q2 2021 and held it in 14 quarters. The position peaked at $31.6M in Q3 2021. 185 funds tracked by Wall St. Rank hold MRVI as of Q4 2024.

  • D.E. Shaw & Co reported no remaining Maravai LifeSciences position as of Q4 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 119,123 Maravai LifeSciences shares in Q4 2024, an estimated $990K.
  • D.E. Shaw & Co first reported a position in Maravai LifeSciences in Q2 2021 and held it in 14 quarters.
  • D.E. Shaw & Co's Maravai LifeSciences position peaked at $31.6M in Q3 2021.
  • 185 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2024.

Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.